type 1 diabetes
Low doses of a cancer drug may be able to act as a preventive drug against the development of Type 1 diabetes, according to new findings.
Investigators at the Harvard Stem Cell Institute have discovered a hormone with the ability to produce beta cells--the insulin-producing cells found in the pancreas that are lost in diabetes--that could potentially treat type 2 diabetes more effectively.
Doctors have identified several newer biomarkers that appear to predict the onset of a damaging, diabetes-related kidney complication.
Researchers in Austria were able to both identify and isolate adult pancreatic stem cells, and then trigger their transformation into functioning, insulin-producing cells that behaved in response to glucose, Medical News Today reports. After initial success in a test tube, the team also generated promising results in mice.
German clinical proteomics company Mosaiques Diagnostics, along with researchers from Australia and Europe, is looking at using proteomics to create a urine test to spot diabetic nephropathy, a progressive kidney disease that is a complication of long-term diabetes.
Researchers in Australia have found that apolipoproteins, proteins that bind fats in the body, may be better biomarkers for diabetics than lipids, according to a study published in Diabetes.
The levels of diabetes are climbing worldwide, both Type 1 and Type 2, and this means that the numbers of people with diabetes-related complications are climbing, too. These include diabetic neuropathy, which affects around half of people with diabetes, and tends to be under-diagnosed.
A dose of antibodies, a bone marrow transplant and treatment with pancreas growth factor helped cure late-stage Type 1 diabetes in mice, researchers have found.
A gene expression profile could be used to predict how easy it will be to control someone's blood glucose in Type 1 diabetes, according to a small study carried out in Australia. Good glycemic control is vital for avoiding, or at least delaying, some of the unpleasant or life-threatening outcomes linked with long-term diabetes.
Though previous attempts to re-create a single person's immune system in a mouse have largely failed, Columbia University Medical Center scientists say they've succeeded this time.